Source: PR Newswire

Press Release: Alcyone Lifesciences : Alcyone Lifesciences Announces Presentation on Intrathecal Physical Methods of Delivery of Gene Therapeutics at 2018 American Society of Cell and Gene Therapy Conference

LOWELL, Mass., May 15, 2018 /PRNewswire/ -- Alcyone Lifesciences, Inc., a leader in disease modifying therapies for the central nervous system (CNS) through its Advanced Precision Delivery Platforms, announced a presentation on its intrathecal delivery technology platform that has the...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
PJ Anand's photo - President & CEO of Alcyone Lifesciences, Inc.

President & CEO

PJ Anand

CEO Approval Rating

83/100

Read more